Pneumonitis resulting from radiation and immune checkpoint blockade illustrates characteristic clinical, radiologic and circulating biomarker features

by Jonathan D. Schoenfeld, Mizuki Nishino, Mariano Severgnini, Michael Manos, Raymond H. Mak, F. Stephen Hodi
Published 2019-04-01

Low dose chest CT protocol (50 mAs) as a routine protocol for comprehensive assessment of intrathoracic abnormality

by Takeshi Kubo, Yoshiharu Ohno, Mizuki Nishino, Pei-Jan Lin, Shiva Gautam, Hans-Ulrich Kauczor, Hiroto Hatabu
Published 2016-01-01

Standard-dose vs. low-dose CT protocols in the evaluation of localized lung lesions: Capability for lesion characterization—iLEAD study

by Takeshi Kubo, Yoshiharu Ohno, Daisuke Takenaka, Mizuki Nishino, Shiva Gautam, Kazuro Sugimura, Hans Ulrich Kauczor, Hiroto Hatabu
Published 2016-01-01

Interstitial lung abnormality in stage IV non-small cell lung cancer: A validation study for the association with poor clinical outcome

by Tetsuro Araki, Suzanne E. Dahlberg, Tomoyuki Hida, Christine A. Lydon, Michael S. Rabin, Hiroto Hatabu, Bruce E. Johnson, Mizuki Nishino
Published 2019-01-01

Tumor volume dynamics and tumor growth rate in ALK-rearranged advanced non-small-cell lung cancer treated with crizotinib

by Mizuki Nishino, Tomoyuki Hida, Sasha Kravets, Suzanne E. Dahlberg, Christine A. Lydon, Hiroto Hatabu, Bruce E. Johnson, Mark M. Awad
Published 2020-01-01

Anterior mediastinal masses in the Framingham Heart Study: Prevalence and CT image characteristics

by Tetsuro Araki, Mizuki Nishino, Wei Gao, Josée Dupuis, George R. Washko, Gary M. Hunninghake, Takamichi Murakami, George T. O’Connor, Hiroto Hatabu
Published 2015-01-01

BRAF-Mutant Pulmonary Langerhans Cell Histiocytosis Mimicking Recurrence of Early-Stage KRAS-Mutant Lung Adenocarcinoma

by Stephanie L. Alden, BA, Scott J. Swanson, MD, Mizuki Nishino, MD, Lynette M. Sholl, MD, Mark M. Awad, MD, PhD
Published 2021-02-01

Interstitial lung abnormalities in patients with stage I non-small cell lung cancer are associated with shorter overall survival: the Boston lung cancer study

by Tomoyuki Hida, Akinori Hata, Junwei Lu, Vladimir I. Valtchinov, Takuya Hino, Mizuki Nishino, Hiroshi Honda, Noriyuki Tomiyama, David C. Christiani, Hiroto Hatabu
Published 2021-01-01

Correction: Targeting PARP-1 with metronomic therapy modulates MDSC suppressive function and enhances anti-PD-1- immunotherapy in colon cancer

by Mark Awad, Mizuki Nishino, Mariano Severgnini, Biagio Ricciuti, Joao V Alessi, Gonzalo Recondo, Marissa Lawrence, Greg Jones, Tim Forshew, Christine Lydon, Michael Cheng
Published 2021-03-01

Early plasma circulating tumor DNA (ctDNA) changes predict response to first-line pembrolizumab-based therapy in non-small cell lung cancer (NSCLC)

by Mark Awad, Mizuki Nishino, Mariano Severgnini, Biagio Ricciuti, Joao V Alessi, Gonzalo Recondo, Marissa Lawrence, Greg Jones, Tim Forshew, Christine Lydon, Michael Cheng
Published 2021-03-01

Use of targeted next generation sequencing to characterize tumor mutational burden and efficacy of immune checkpoint inhibition in small cell lung cancer

by Biagio Ricciuti, Sasha Kravets, Suzanne E. Dahlberg, Renato Umeton, Adem Albayrak, Safiya J. Subegdjo, Bruce E. Johnson, Mizuki Nishino, Lynette M. Sholl, Mark M. Awad
Published 2019-03-01

Projected lung areas using dynamic X-ray (DXR)

by Takuya Hino, Akinori Hata, Tomoyuki Hida, Yoshitake Yamada, Masako Ueyama, Tetsuro Araki, Takeshi Kamitani, Mizuki Nishino, Atsuko Kurosaki, Masahiro Jinzaki, Kousei Ishigami, Hiroshi Honda, Hiroto Hatabu, Shoji Kudoh
Published 2020-01-01

Leptomeningeal Response to Capmatinib After Progression on Crizotinib in a Patient With MET Exon 14–Mutant NSCLC

by Paola Cravero, MD, Nuno Vaz, MD, Biagio Ricciuti, MD, Sarah E. Clifford, MPH, Gianluca DiUbaldi, BS, BA, Dawn Drevers, RN, Kaitlin Morton, BS, Rebecca E. Rivenburgh, BS, Mizuki Nishino, MD, MPH, Mark M. Awad, MD, PhD
Published 2020-11-01

Progression of traction bronchiectasis/bronchiolectasis in interstitial lung abnormalities is associated with increased all-cause mortality: Age Gene/Environment Susceptibility-Rey...

by Takuya Hino, Tomoyuki Hida, Mizuki Nishino, Junwei Lu, Rachel K. Putman, Elias F. Gudmundsson, Akinori Hata, Tetsuro Araki, Vladimir I. Valtchinov, Osamu Honda, Masahiro Yanagawa, Yoshitake Yamada, Takeshi Kamitani, Masahiro Jinzaki, Noriyuki Tomiyama, Kousei Ishigami, Hiroshi Honda, Raul San Jose Estepar, George R. Washko, Takeshi Johkoh, David C. Christiani, David A. Lynch, Vilmundur Gudnason, Gunnar Gudmundsson, Gary M. Hunninghake, Hiroto Hatabu
Published 2021-01-01

Association Between Immune-Related Adverse Events and Clinical Outcomes to Programmed Cell Death Protein 1/Programmed Death-Ligand 1 Blockade in SCLC

by Biagio Ricciuti, MD, Abdul Rafeh Naqash, MD, Jarushka Naidoo, MD, Kartik Sehgal, MD, Adam Miller, MD, Kenneth Kehl, MD, MPH, Deepti Venkatraman, MPH, Jacob Sands, MD, Giuseppe Lamberti, MD, Gonzalo Recondo, MD, PhD, Jiajia Zhang, MD, Shravanti Macherla, MD, Sameer Baig, MD, Paul Walker, MD, Deepa Rangachari, MD, Justin F. Gainor, MD, Daniel B. Costa, MD, Naiyer Rizvi, MD, Lynette M. Sholl, MD, Mizuki Nishino, MD, MPH, Brian Henick, MD, Anna F. Farago, MD, PhD, Mark M. Awad, MD, PhD
Published 2020-11-01